

































































































































































































































































































































































































































































































































































































































































































































diagnosis: the characterisation of an organism, disease state, phenotype or response to an intervention 
exposome: all those chemicals in the environment to which a human is exposed.[69] 
GWAS (genome-wide association study): an observational study that aims to associate a particular 
biological trait with a genetic variant 
MWAS (metabolite-wide association study): an observational study that aims to associate a 
particular biological trait such as disease state with metabolic variation or phenotype 
metabolic biomarker: a structurally-defined metabolite or metabolic feature, verified to be 
associated with a particular phenotypic, disease, diagnostic or prognostic class and that can be used 
specifically to identify those classes or states 
metabolic entropy: the degree of disorder of metabolite characteristics, such as concentrations, in an 
individual or in a group of subjects 
metabotype: multicomponent metabolic characteristics that result from the cumulative interactions of 
genetic variation, gene products and environmental exposures and that can be related directly to 
disease risks and therapeutic responses, also known as the metabolic phenotype 
metabolic trajectory: the changes in metabolite concentrations over time in response to an 
intervention 
metabolite: a compound in a biological matrix of an organism that is produced in that organism by an 
enzymatic pathway 
metabolomics: metabolic profiling defined in an observational fashion as ‘a comprehensive analysis 
in which all the metabolites of a biological system are identified and quantified’ 
metabolome: the full set of metabolites within, or that can be secreted from, a biological system such 
as a cell type or tissue 
metabonate: a compound in a biological matrix of an organism that is produced in that organism by a 
chemical pathway without enzymatic involvement. This term is also used to describe molecular 
artifacts produced chemically during sample extraction, isolation, purification or analysis procedures 
metabonomics: metabolic profiling defined in an experimental fashion as ‘the quantitative 
measurement of the multiparametric metabolic response of living systems to pathophysiological 
stimuli or genetic modification’ 
metabotypes or metabolic phenotypes: are the multicomponent metabolic characteristics that result 
from the cumulative interactions of genetic variation, gene products and environmental exposures that 
can be related directly to disease risks and therapeutic responses. The metabotype is a probabilistic, 
multiparametric description of an organism in a given physiological state based on analysis of its cell 
types, biofluids and tissues  
microbiome: the collection of microorganisms present both in and on an organism, in a variety of 
environmental niches: the bacteriome, virome and mycobiome refer to the collection of bacteria, 
viruses and fungi, that constitute the microbiome 
MVA (multivariate [statistical] analysis): a method for the analysis of multiple variables in an 
experiment or observation at a time and the simplification of the analysis problem by reduction of the 
large number of initial variables to a small number of key factors 
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parasitome: the collection of parasites associated with the host organism. 
personalized medicine: the use of genomic, molecular and clinical information to select treatments 
or medicines that are more likely to be both effective and safe for that patient: also known as precision 
medicine or stratified medicine 
pharmacogenomics: the prediction of the effects of a drug on the basis of individual genetic profiles  
pharmacometabolomics: this term is used synonymously with pharmacometabonomics (see below), 
but is sometimes erroneously used to describe the investigation of the effects of a drug on an 
organism: this is just diagnostic metabonomics 
pharmacometabonomics: the prediction of the properties of a drug (efficacy, toxicity, metabolism, 
pharmacokinetics) on the basis of a mathematical model of pre-dose metabolite profiles 
pharmacometagenomics: the prediction of the properties of a drug on the basis of a mathematical 
model of pre-dose microbiome profiles 
phenotype: the quantitative or qualitative measurement of specific parameters or traits that 
characterise individual functional biological classes or groups 
predictive metabolic phenotyping: the prediction of the outcome of an intervention in an individual 
based on a mathematical model of pre-intervention metabolite profiles. The intervention could be a 
change in diet, exercise, the passage of time, surgical treatment etc. Pharmacometabonomics is one 
specific case of predictive metabolic phenotyping in which the intervention is drug treatment 
prognosis: the prediction of disease onset, disease outcome or the outcome of an intervention such as 
drug treatment	
